Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

Abstract Central venous thrombosis is a complex problem, particularly in cases where the thrombus burden is large. Several interventional techniques and devices have been developed over the past 15 to 20 years to manage this entity, but the vast majority of them still need the concomitant use of thr...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in interventional radiology 2015-12, Vol.32 (4), p.374-378
Main Authors: Behrens, George, Bjarnason, Haraldur
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Central venous thrombosis is a complex problem, particularly in cases where the thrombus burden is large. Several interventional techniques and devices have been developed over the past 15 to 20 years to manage this entity, but the vast majority of them still need the concomitant use of thrombolytics to achieve an optimal result. AngioVac (AngioDynamics, Latham, NY) is the first aspiration thrombectomy device capable to remove a larger burden of undesired intravascular material such as thrombus, tumor, and foreign bodies without the need of lytics. This review focuses on the AngioVac device in the management of iliocaval thrombosis and pulmonary embolism.
ISSN:0739-9529
1098-8963
DOI:10.1055/s-0035-1564792